Forbes Rich List Has Implications for Global Philanthropy
The richest man in the world is no longer an American but a Mexican, a sign of the developing world’s wealth -- and potentially foreshadowing a shift in philanthropy.
Video: Warren Buffett’s Battle Against Poverty
Follow the philanthropist Warren E. Buffett on his recent trip to New Orleans to work with Purpose-Built Communities, a nonprofit advisory group that is helping cities across the country fight poverty.
Bill Clinton and Bill Gates Ask for Global-Health Spending Increase
Bill Clinton and Bill Gates team up to ask Congress for an increase in global-health spending.
Warren Buffett Shares His Philanthropic Philosophy
During a panel on antipoverty work last week in New Orleans, the investor Warren E. Buffett talked about how he picks charities to support.
3 Philanthropists Bet on New Orleans Venture as an Antipoverty Model
Three wealthy philanthropists -- Warren E. Buffett, Thomas G. Cousins, and Julian H. Robertson Jr. -- hope to turn a poor New Orleans neighborhood demolished by Hurricane Katrina into an antipoverty model.
Debate Over the Purpose of Jewish Philanthropy
Should Jewish philanthropy focus more on helping needy Jewish people?
Huffington Post’s Nonprofit Reporting Under Fire
The Huffington Post’s philanthropy reporting is under fire for working with a fund-raising company to produce content, a relationship some journalism experts fear might cause ethical problems.
Could Obama’s Social Innovation Fund Hurt Foundation Advocacy?
Nonprofit leaders are raising increased concern that the government and grant makers are getting too cozy.
Debate Continues Over Plan to Use Federal Fund to Promote Effective Charities
The Obama administration’s plan to give federal grants to promote effective charities through the Social Innovation Fund continues to stir up strong feelings among critics and supporters.
Gates Official’s Former Role at Drug Company Comes Under Scrutiny
The head of global health for the Bill & Melinda Gates Foundation is under scrutiny by members of Congress for his previous job at one of the world’s largest pharmaceutical companies.